KERYX BIOPHARMACEUTICALS INC's ticker is KERX and the CUSIP is 492515101. A total of 126 filers reported holding KERYX BIOPHARMACEUTICALS INC in Q4 2013. The put-call ratio across all filers is 1.12 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2016 | $1,725,000 | +10.0% | 294,398 | -0.3% | 0.00% | 0.0% |
| Q3 2016 | $1,568,000 | -20.0% | 295,306 | -0.3% | 0.00% | 0.0% |
| Q2 2016 | $1,960,000 | +20.0% | 296,076 | -15.4% | 0.00% | 0.0% |
| Q1 2016 | $1,634,000 | -6.1% | 349,878 | +1.6% | 0.00% | 0.0% |
| Q4 2015 | $1,740,000 | +43.7% | 344,472 | +0.2% | 0.00% | 0.0% |
| Q3 2015 | $1,211,000 | -65.3% | 343,897 | -1.6% | 0.00% | -50.0% |
| Q2 2015 | $3,489,000 | -2.0% | 349,565 | +25.0% | 0.00% | -20.0% |
| Q1 2015 | $3,559,000 | +1.1% | 279,608 | +12.4% | 0.01% | 0.0% |
| Q4 2014 | $3,521,000 | +2.3% | 248,814 | -0.6% | 0.01% | 0.0% |
| Q3 2014 | $3,441,000 | -10.6% | 250,255 | +0.0% | 0.01% | 0.0% |
| Q2 2014 | $3,847,000 | -8.3% | 250,130 | +1.6% | 0.01% | -16.7% |
| Q1 2014 | $4,194,000 | +44.2% | 246,129 | +9.6% | 0.01% | +50.0% |
| Q4 2013 | $2,909,000 | +25.0% | 224,609 | -2.7% | 0.00% | 0.0% |
| Q3 2013 | $2,328,000 | +42.7% | 230,772 | +5.7% | 0.00% | +33.3% |
| Q2 2013 | $1,631,000 | – | 218,353 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| HUNTINGTON NATIONAL BANK | 1 | $3 | 0.00% |